Home About us Contact
|
Home About us Contact | ||
|
|
||
Initial Discovery (initial + discovery)
Selected AbstractsFunctional characterization of human nucleosome assembly protein 1-like proteins as histone chaperonesGENES TO CELLS, Issue 1 2010Mitsuru Okuwaki Nucleosome Assembly Protein 1 (NAP1) is a highly conserved histone chaperone protein suspected to be involved in the dynamical regulation of the histone H2A-H2B hetero-dimer. However, the exact mechanism by which NAP1-like proteins act is currently unknown. In this work, we characterized the biochemical properties of two human NAP1-like proteins, hNAP1L1 and hNAP1L4, including a previously uncharacterized subtype, with the aim of determining their exact mechanistic role. Both hNAP1L1 and hNAP1L4 were found to be localized mainly to the cytoplasm and a minor population of them was suggested to be in the nucleus. Biochemical analyses demonstrated that both hNAP1L1 and hNAP1L4 mediated nucleosome formation. In addition, hNAP1L1 was shown to possess a significantly greater nucleosome disassembly activity than hNAP1L4, suggesting that hNAP1L1 and hNAP1L4 may play distinct roles in the regulation of histone dynamics. Building upon this initial discovery we also found that histone H2A-H2B and various histone H2A variants-H2B dimers were found to associate with both hNAP1L1 and hNAP1L4 in cell extracts. These results suggest that human NAP1-like proteins play overlapping roles in transport and deposition of histone H2A-H2B or H2A variants-H2B dimers on chromatin and nonoverlapping roles in nucleosome disassembly. [source] Endothelial cell-specific molecule 2 (ECSM2) modulates actin remodeling and epidermal growth factor receptor signalingGENES TO CELLS, Issue 3 2009Fanxin Ma Endothelial cell-specific molecules (ECSMs) play a pivotal role in the pathogenesis of many angiogenesis-related diseases. Since its initial discovery, the exact function of human ECSM2 has not been defined. In this study, by database mining, we identified a number of hypothetical proteins across species exhibiting substantial sequence homology to the human ECSM2. We showed that ECSM2 is preferentially expressed in endothelial cells and blood vessels. Their characteristic structures and unique expression patterns suggest that ECSM2 is an evolutionarily conserved gene and may have important functions. We further explored the potential roles of human ECSM2 at the molecular and cellular level. Using a reconstitution mammalian cell system, we demonstrated that ECSM2 mainly resides at the cell membrane, is critically involved in cell-shape changes and actin cytoskeletal rearrangement, and suppresses tyrosine phosphorylation signaling. More importantly, we uncovered that ECSM2 can cross-talk with epidermal growth factor receptor (EGFR) to attenuate the EGF-induced cell migration, possibly via inhibiting the Shc-Ras-ERK (MAP kinase) pathway. Given the importance of growth factor and receptor tyrosine kinase-mediated signaling and cell migration in angiogenesis-related diseases, our findings regarding the inhibitory effects of ECSM2 on EGF-mediated signaling and cell motility may have important therapeutic implications. [source] CURRENT STATUS OF THE INVASIVE GREEN ALGA CODIUM FRAGILE IN EASTERN CANADAJOURNAL OF PHYCOLOGY, Issue 2000D.J. Garbary Ten years after the initial discovery of Codium fragile in eastern Canada on the Atlantic coast of Nova Scotia, C. fragile has extended its range considerably to northern Nova Scotia, southern New Brunswick and Prince Edward Island (P.E.I.) in the Gulf of St. Lawrence. In all principal areas C. fragile subsp. tomentosoides is present. In two regions of Prince Edward Island, Codium is becoming extremely abundant, and is known by local fishers as the "oyster thief". A potential second taxon of Codium was collected in 1999 at three sites in Malpeque Bay where it is locally abundant. These plants are distinguished from C. fragile subsp. tomentosoides by their smaller frond size, flatter utricle tops, smaller mucrons, and smaller gametangia. Principal component analysis distinguishes plants of the two types. The abundance of C. fragile on both hard bottom and soft bottom substrata suggests that it will become the dominant alga in many subtidal algal communities in eastern Canada. [source] Dendritic macromolecules at the interface of nanoscience and nanotechnologyMACROMOLECULAR SYMPOSIA, Issue 1 2003Jean M.J. Fréchet Abstract As a result of their unique architecture and structural as well as functional versatility, dendrimers have generated considerable interest in numerous areas of the physical sciences, engineering, as well as the biological sciences. Both their size - in the 1-10 nm range - and their globular shape resemble those of many proteins suggesting a host of biomimetic and nanotechnological applications. This brief highlight describes some of our recent work with nascent applications of dendrimers as unimolecular nanoreactors, as nanoscale antennae for energy harvesting and transduction, and as nanosized carriers for diagnostic or therapeutic applications. While implementation of some of these applications may still be distant, the impatient critic might remember that new markets are not created overnight as demonstrated by the slow commercial acceptance of many promising molecules and technologies with development frequently extending decades after their initial discovery. [source] A short history of the initial discovery of the Wolf,Hirschhorn syndrome,AMERICAN JOURNAL OF MEDICAL GENETICS, Issue 4 2008Kurt Hirschhorn Abstract Deletion of the short arm of chromosome 4 (4p-) was first described in 1961 [Hirschhorn and Cooper, 1961], and the second case of 4p- was published in 1965 [Hirschhorn et al., 1965]. This short history describes the original case and the sequence of events leading to the publications. © 2008 Wiley-Liss, Inc. [source] Doing Homogeneous Catalysis between Basic Research and ApplicationCHEMIE-INGENIEUR-TECHNIK (CIT), Issue 8 2006M. BellerArticle first published online: 3 AUG 200 Abstract Recent achievements in applied homogeneous catalysis are described. Special focus is given on the development of novel palladium catalysts which are of industrial interest for the synthesis of bulk and fine chemicals. Most of the reported work has been done in an intensive collaboration between the Degussa AG (DHC) and the Leibniz-Institut für Katalyse e.V. The clear vision of the goal and a close interaction of basic research and applied catalysis have led to a fast development from the initial discovery to the upscaling of the ligands. Such a combination of know how from academic and industrial partners will provide the basis for further innovations in catalysis in future. [source] Tubulointerstitial nephritis and uveitis (TINU) syndrome: a case report and review of the literatureACTA OPHTHALMOLOGICA, Issue 6 2009Veronica Holm Thomassen Abstract. Purpose:, We aim to describe the first case of tubulointerstitial nephritis and uveitis (TINU) syndrome reported in Scandinavia and to underline the importance of the syndrome, which should be better known among ophthalmologists. Methods:, We report an 11-year-old boy who was admitted to hospital because of general fatigue and weight loss. Blood tests showed renal insufficiency and a renal biopsy revealed acute tubulointerstitial nephritis. One week after admission the patient developed transitory blurred vision and flickering shadows in the left eye. Slit-lamp examination revealed bilateral anterior non-granulomatous uveitis and TINU syndrome was diagnosed. Results:, Because of renal insufficiency the patient was treated with systemic prednisone 50 mg/day for 3 weeks. Evolution was favourable, and prednisone was tapered over 10 weeks. Uveitis was treated with topical steroid with good effect. The only complication after 18 months of follow-up was transitory cushingoid aspect. Conclusions:, Tubulointerstitial nephritis and uveitis syndrome is a rare syndrome that is probably underdiagnosed in clinical practice. Co-operation between ophthalmologists and nephrologists/paediatricians is crucial for early diagnosis and instigation of treatment. Uveitis may occur before tubulointerstitial nephritis or the renal symptoms may be so mild that the patient is unaware of them. Therefore, ophthalmologists play an important role in the initial discovery of patients with TINU syndrome. Tubulointerstitial nephritis tends to be self-limiting, whereas uveitis tends to relapse and recurrences tend to be more severe than the initial uveitis. Therefore, the patient must be ophthalmologically monitored very carefully. [source] | ||||||||||